Determinants of protection among HIV‐exposed seronegative persons: an overview.
about
HIV-1 prophylactic vaccines: state of the artSIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerationsCommon human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States.Regulatory variation in HIV-1 dependency factor ZNRD1 associates with host resistance to HIV-1 acquisitionEpitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.Immunodeficiency lentiviral infections in natural and non-natural hosts.p21(WAF1/CIP1) RNA expression in highly HIV-1 exposed, uninfected individualsImmunogenetic influences on acquisition of HIV-1 infection: consensus findings from two African cohorts point to an enhancer element in IL19 (1q32.2).Serum protein electrophoresis under effective control of HIV-1 disease progression.Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.Increased frequency of circulating Tc22/Th22 cells and polyfunctional CD38(-) T cells in HIV-exposed uninfected subjects.Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.Host genomic influences on HIV/AIDS.Antiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples.Prevention of SHIV transmission by topical IFN-β treatment.HIV sexual transmission and microbicides.Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).HIV controllers: a multifactorial phenotype of spontaneous viral suppression.Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects.Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier.Risk of HIV Infection and Lethality Are Decreased in CCR5del32 Heterozygotes: Focus Nosocomial Infection Study and Meta-analysis.A Role for Fc-Mediated Humoral Immunity in Reducing HIV Transmission Rates between HIV Serodiscordant Heterosexual Couples.
P2860
Q26740042-E617334C-2761-4DD0-825B-6C04CC86C293Q27340281-96041EAF-C1AE-47B5-8C07-364B94D5E8FBQ29417119-12AEFC20-3002-44C5-9066-5C26E95F138DQ30217421-36253CF8-EC6E-4584-B580-BB333DCAC8EEQ34430206-66E9ABE1-17D5-41A3-B833-222D00E763E9Q34548297-C62CFDAB-BE7E-46FC-9FE0-4F21662A16BAQ35140973-EE0F8EC5-2B77-4C8C-A2CC-6CA5F6600602Q35154844-01EC5B1D-5772-4AA7-8C07-9F7C7D7006C8Q35537033-B49A9CBF-5456-420B-B56F-84B8091AD1FDQ35728932-A9BF5595-B779-4628-B2A3-32BAC1DEBF67Q35845726-70AD10C3-255D-42FD-AAFE-6E6F8BDEA028Q36034170-3526992B-987C-4890-A1AE-7FDD50EA2E7FQ36253005-FB45F3D4-CD60-4401-9926-4CDBEC787D0EQ36731398-92400926-5885-4AB4-A166-E52E1C908063Q36872470-DE96D2BC-90EB-4170-A3BA-038684387FDCQ36889962-710E408D-BDDD-46C4-8885-185D45B25587Q37150111-D78B2B1C-2334-4F83-91A6-1D18DF61FE3AQ37853935-4121D5F0-A078-4EEB-989A-B179A153C57FQ37854081-E10A6E9A-2BB6-4C42-B3EE-0BE82F991B60Q37921949-6D1A6EA0-B0AC-4F60-97ED-C88652C161C4Q39180288-E0DBD92C-53ED-407C-A3FF-4AF48C95E794Q39291840-A6016BED-CBBC-4703-A567-A3491E67F186Q42003237-0CBEFA41-862B-43E5-9F00-A79BD7C4EE8AQ49647394-A504E700-ABC7-4F31-8331-A85B8C6D6240
P2860
Determinants of protection among HIV‐exposed seronegative persons: an overview.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Determinants of protection among HIV‐exposed seronegative persons: an overview.
@ast
Determinants of protection among HIV‐exposed seronegative persons: an overview.
@en
type
label
Determinants of protection among HIV‐exposed seronegative persons: an overview.
@ast
Determinants of protection among HIV‐exposed seronegative persons: an overview.
@en
prefLabel
Determinants of protection among HIV‐exposed seronegative persons: an overview.
@ast
Determinants of protection among HIV‐exposed seronegative persons: an overview.
@en
P2093
P2860
P356
P1476
Determinants of protection among HIV‐exposed seronegative persons: an overview.
@en
P2093
Aaron Weinberg
Clifford Harding
Daniel C Douek
David B Goldstein
Demetre C Daskalakis
Donald Anthony
Galit Alter
Gareth Hardy
James J Goedert
Leonid Margolis
P2860
P304
P356
10.1086/655967
P407
P478
202 Suppl 3
P577
2010-11-01T00:00:00Z